Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > Interview of Lee
View:
Comment by Ingiboy on Feb 28, 2022 10:57am
I had trouble watching this interview.  Did we hear anything new......no.       If you were hoping to get some sort of update you were sadly mistaken.  Even though this interview was done last week it sounde like it was done a year ago with the same old general comments.  Nothing new regarding the Monasterium Lab tests with the Dermal Injector.  The most ...more  
Comment by MetzGER on Feb 28, 2022 11:20am
Ingiboy i agree that there wasnt new informations and the interview could have Been 1 Year Old. But regarding the Shiseido Situation it wouldnt be very clever if he tells about arbitration with One of the biggest cosmetic companys. It wouldnt Attract Investors if they think about potential law fights with Replicel if Replicel already had beef with shisheido than beef with other companies could ...more  
Comment by Ingiboy on Feb 28, 2022 1:56pm
So why do an interview of this nature at all if you don't have all your ducks in a row.  Granted it is a reach out to new investors but this is not the time if you can't be truthful with what is really going on.
Comment by MetzGER on Feb 28, 2022 4:31pm
I am grateful that Lee is still alive 
Comment by Ingiboy on Mar 02, 2022 2:18pm
Grateful for what ?   Something is definetly going on casuing this lack of update on the company.  Obviously something is preventing them from updating the shareholders.  Is it good or bad ? Good:   Replicel is close to settling with Shiseido A large Pharma is wanting to buy Replicel Mainpointe is close to sending Dermaprecise to the FDA for Approval Replicel has a new partner ...more  
Comment by MetzGER on Mar 03, 2022 3:18am
For sure the Szenario "good" !! FINALLY!: https://youtu.be/y2ak_oBeC-I
Comment by bluemoons20 on Mar 03, 2022 10:56am
Easy to pick the scenario  best  for all shareholders. However,  on the comment about something must be happenning  to  prevent updating shareholders  .  I really  wonder about that. I have bee in this stock  (hoping  for a miracle)  for years  now  and  updates  are few and far between all the time  , not just when ...more  
Comment by Ingiboy on Mar 03, 2022 11:50am
Yes bluemoons20 it will take a miracle.  Over the years just when I would get down on this company and it's mangement I would hear something encouraging and buy some more stock. I have done that many times which I am increasing feeling was a mistake. I am now sitting on a large pile of worthless stock.  I will not invest another penny in this pile of shite.  So my advice to you ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities